These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36300773)

  • 1. Cutaneous adverse drug eruption: the role of drug patch testing.
    Thaiwat S; Rojanapanthu P
    Int J Dermatol; 2023 Jan; 62(1):108-114. PubMed ID: 36300773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic patch testing following tuberculosis-associated cutaneous adverse drug reactions induces systemic reactions in HIV-infected persons.
    Lehloenya RJ; Todd G; Wallace J; Ngwanya MR; Muloiwa R; Dheda K
    Br J Dermatol; 2016 Jul; 175(1):150-6. PubMed ID: 26918554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saline Vehicle Increases the Ability of Drug Patch Test in Cutaneous Adverse Drug Reactions.
    Thaiwat S; Prompongsa S
    Dermatology; 2023; 239(2):241-247. PubMed ID: 36599331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of patch tests in the diagnosis of delayed hypersensitivity drug eruptions.
    Hassoun-Kheir N; Bergman R; Weltfriend S
    Int J Dermatol; 2016 Nov; 55(11):1219-1224. PubMed ID: 27368159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Wolkenstein P; Chosidow O; Fléchet ML; Robbiola O; Paul M; Dumé L; Revuz J; Roujeau JC
    Contact Dermatitis; 1996 Oct; 35(4):234-6. PubMed ID: 8957644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Study of Cutaneous Adverse Drug Reactions at a Tertiary Care Center in Andhra Pradesh, India.
    Ashifha S; Vijayashree J; Vudayana K; Chintada D; P P; G P; Unnikrishnan P
    Cureus; 2023 Apr; 15(4):e37596. PubMed ID: 37197134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions.
    Barbaud A; Collet E; Milpied B; Assier H; Staumont D; Avenel-Audran M; Grange A; Amarger S; Girardin P; Guinnepain MT; Truchetet F; Lasek A; Waton J;
    Br J Dermatol; 2013 Mar; 168(3):555-62. PubMed ID: 23136927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug patch tests in the investigation of cutaneous adverse drug reactions].
    Barbaud A
    Ann Dermatol Venereol; 2009; 136(8-9):635-44. PubMed ID: 19686903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse cutaneous drug eruptions: current understanding.
    Hoetzenecker W; Nägeli M; Mehra ET; Jensen AN; Saulite I; Schmid-Grendelmeier P; Guenova E; Cozzio A; French LE
    Semin Immunopathol; 2016 Jan; 38(1):75-86. PubMed ID: 26553194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Review of Fixed Drug Eruption with a Special Focus on Generalized Bullous Fixed Drug Eruption.
    Anderson HJ; Lee JB
    Medicina (Kaunas); 2021 Sep; 57(9):. PubMed ID: 34577848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bullous fixed drug eruption masquerading as recurrent Stevens Johnson syndrome.
    Dharamsi FM; Michener MD; Dharamsi JW
    J Emerg Med; 2015 May; 48(5):551-4. PubMed ID: 25433836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of thymus and activation-regulated chemokine (TARC/CCL17) as a potential marker for early indication of disease and prediction of disease activity in drug-induced hypersensitivity syndrome (DIHS)/drug rash with eosinophilia and systemic symptoms (DRESS).
    Ogawa K; Morito H; Hasegawa A; Daikoku N; Miyagawa F; Okazaki A; Fukumoto T; Kobayashi N; Kasai T; Watanabe H; Sueki H; Iijima M; Tohyama M; Hashimoto K; Asada H
    J Dermatol Sci; 2013 Jan; 69(1):38-43. PubMed ID: 23141052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4 count and risk of anti-tuberculosis drug-associated cutaneous reactions in HIV-infected Thai patients.
    Boonyagars L; Hirunwiwatkul P; Hurst CP
    Int J Tuberc Lung Dis; 2017 Mar; 21(3):338-344. PubMed ID: 28225346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential diagnosis of severe cutaneous drug eruptions.
    Bachot N; Roujeau JC
    Am J Clin Dermatol; 2003; 4(8):561-72. PubMed ID: 12862499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drugs and the skin: A concise review of cutaneous adverse drug reactions.
    Del Pozzo-Magaña BR; Liy-Wong C
    Br J Clin Pharmacol; 2024 Aug; 90(8):1838-1855. PubMed ID: 35974692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clindamycin-induced Maculopapular Exanthema with Preferential Involvement of Striae Distensae: A Koebner phenomenon?
    Monteagudo B; Cabanillas M; Iriarte P; Ramírez-Santos A; León-Muinos E; González-Vilas D; Suárez-Amor Ó
    Acta Dermatovenerol Croat; 2018 Apr; 26(1):61-63. PubMed ID: 29782303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations.
    Hsiao YH; Hui RC; Wu T; Chang WC; Hsih MS; Yang CH; Ho HC; Chang YG; Chen MJ; Lin JY; Chen DP; Chang PY; Wu TL; Hung SI; Chung WH
    J Dermatol Sci; 2014 Feb; 73(2):101-9. PubMed ID: 24268988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical resemblance of widespread bullous fixed drug eruption to Stevens-Johnson syndrome or toxic epidermal necrolysis: report of two cases.
    Lin TK; Hsu MM; Lee JY
    J Formos Med Assoc; 2002 Aug; 101(8):572-6. PubMed ID: 12440088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic drug reactions with skin involvement: Stevens-Johnson syndrome, toxic epidermal necrolysis, and DRESS.
    Darlenski R; Kazandjieva J; Tsankov N
    Clin Dermatol; 2015; 33(5):538-41. PubMed ID: 26321400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patch testing versus interferon-gamma release assay in evaluation of drug eruptions.
    Kaplan Y; Goldberg I; Sprecher E; Slodownik D
    Fundam Clin Pharmacol; 2022 Apr; 36(2):414-420. PubMed ID: 34668222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.